HUMAN MICROBIOME SEQUENCING TECHNOLOGY MARKET ANALYSIS BY TYPE, APPLICATION, REGIONS AND COMPANIES FORECAST
2024-09-13 | Pages: 200+ | Report ID: WR-2024-09-13-5521 | Pharmaceuticals and Healthcare
Historical data: 2018 - 2023
Forecast period: 2024 - 2031
Quantitative units: Revenue in USD million and CAGR from 2024 to 2031
Report coverage: Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Human Microbiome Sequencing Technology Market
1.1 SCOPE OF THE REPORT
1.2 MARKET SEGMENT ANALYSIS
1.3 REGULATORY SCENARIO BY REGION/COUNTRY
1.4 MARKET INVESTMENT SCENARIO STRATEGIC
1.5 MARKET ANALYSIS BY TYPE (USD MILLION)
1.6 MARKET ANALYSIS BY APPLICATION (USD MILLION)
2.1 DRIVER, RESTRAINT, CHALLENGE AND OPPORTUNITIES ANALYSIS
2.1.1 MARKET DRIVER ANALYSIS
2.1.2 MARKET RESTRAINT ANALYSIS
2.1.3 MARKET OPPORTUNITY
2.1.4 MARKET CHALLENGES
3.1 INDUSTRY TRENDS
3.1.1 SWOT ANALYSIS
3.1.2 PESTEL ANALYSIS
3.1.3 PORTER’S FIVE FORCES ANALYSIS
3.2 POTENTIAL MARKET AND GROWTH POTENTIAL ANALYSIS
4.1 COVID-19 ANALYSIS
5.1 GLOBAL HUMAN MICROBIOME SEQUENCING TECHNOLOGY MARKET, SALES AREA, TYPE
5.2 MERGERS & ACQUISITIONS, PARTNERSHIPS, PRODUCT LAUNCH, AND COLLABORATION IN GLOBAL HUMAN MICROBIOME SEQUENCING TECHNOLOGY MARKET
7.1 GLOBAL HUMAN MICROBIOME SEQUENCING TECHNOLOGY MARKET SIZE AND SHARE (2018-2031) (USD MILLION)
8.1 GLOBAL HUMAN MICROBIOME SEQUENCING TECHNOLOGY MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
8.2 GLOBAL HUMAN MICROBIOME SEQUENCING TECHNOLOGY MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
9.1 GLOBAL HUMAN MICROBIOME SEQUENCING TECHNOLOGY MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
9.2 GLOBAL HUMAN MICROBIOME SEQUENCING TECHNOLOGY MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
10.1 GLOBAL HUMAN MICROBIOME SEQUENCING TECHNOLOGY MARKET SIZE AND SHARE BY REGION (2018-2023) (USD MILLION)
10.2 GLOBAL HUMAN MICROBIOME SEQUENCING TECHNOLOGY MARKET SIZE AND SHARE BY REGION (2024-2031) (USD MILLION)
11.1 NORTH AMERICA HUMAN MICROBIOME SEQUENCING TECHNOLOGY MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)
11.2 NORTH AMERICA HUMAN MICROBIOME SEQUENCING TECHNOLOGY MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
11.3 NORTH AMERICA HUMAN MICROBIOME SEQUENCING TECHNOLOGY MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
11.4 NORTH AMERICA HUMAN MICROBIOME SEQUENCING TECHNOLOGY MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
11.5 NORTH AMERICA HUMAN MICROBIOME SEQUENCING TECHNOLOGY MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
11.6 NORTH AMERICA HUMAN MICROBIOME SEQUENCING TECHNOLOGY MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
12.1 EUROPE HUMAN MICROBIOME SEQUENCING TECHNOLOGY MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)
12.2 EUROPE HUMAN MICROBIOME SEQUENCING TECHNOLOGY MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
12.3 EUROPE HUMAN MICROBIOME SEQUENCING TECHNOLOGY MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
12.4 EUROPE HUMAN MICROBIOME SEQUENCING TECHNOLOGY MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
12.5 EUROPE HUMAN MICROBIOME SEQUENCING TECHNOLOGY MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
12.6 EUROPE HUMAN MICROBIOME SEQUENCING TECHNOLOGY MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
13.1 ASIA PACIFIC HUMAN MICROBIOME SEQUENCING TECHNOLOGY MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)
13.2 ASIA PACIFIC HUMAN MICROBIOME SEQUENCING TECHNOLOGY MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
13.3 ASIA PACIFIC HUMAN MICROBIOME SEQUENCING TECHNOLOGY MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
13.4 ASIA PACIFIC HUMAN MICROBIOME SEQUENCING TECHNOLOGY MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
13.5 ASIA PACIFIC HUMAN MICROBIOME SEQUENCING TECHNOLOGY MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
13.6 ASIA PACIFIC HUMAN MICROBIOME SEQUENCING TECHNOLOGY MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
14.1 LATIN AMERICA HUMAN MICROBIOME SEQUENCING TECHNOLOGY MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)/p>
14.2 LATIN AMERICA HUMAN MICROBIOME SEQUENCING TECHNOLOGY MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
14.3 LATIN AMERICA HUMAN MICROBIOME SEQUENCING TECHNOLOGY MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
14.4 LATIN AMERICA HUMAN MICROBIOME SEQUENCING TECHNOLOGY MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
14.5 LATIN AMERICA HUMAN MICROBIOME SEQUENCING TECHNOLOGY MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
14.6 LATIN AMERICA HUMAN MICROBIOME SEQUENCING TECHNOLOGY MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
15.1 MIDDLE EAST & AFRICA HUMAN MICROBIOME SEQUENCING TECHNOLOGY MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)
15.2 MIDDLE EAST & AFRICA HUMAN MICROBIOME SEQUENCING TECHNOLOGY MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
15.3 MIDDLE EAST & AFRICA HUMAN MICROBIOME SEQUENCING TECHNOLOGY MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
15.4 MIDDLE EAST & AFRICA HUMAN MICROBIOME SEQUENCING TECHNOLOGY MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
15.5 MIDDLE EAST & AFRICA HUMAN MICROBIOME SEQUENCING TECHNOLOGY MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
15.6 MIDDLE EAST & AFRICA HUMAN MICROBIOME SEQUENCING TECHNOLOGY MARKET SIZE AND SHARE BY APPLICATION (2024-2031)< (USD MILLION)/p>
16.1 Baseclear B.V.
16.1.1 COMPANY DETAILS
16.1.2 FINANCIALS (USD MILLION)
16.1.3 PRODUCT SUMMARY
16.1.4 RECENT DEVELOPMENTS
16.2 Beijing Genomics Institute (BGI) Genomics Co. Ltd
16.3 Charles River Laboratories International Inc.
16.4 Clinical Microbiomics A/S
16.5 Eurofins Scientific SE
16.6 GENEWIZ Inc.
16.7 Illumina Inc.
16.8 Novogene Corporation
16.9 OraSure Technologies Inc.
16.10 Oxford Nanopore Technologies Inc.
16.11 Pacific Biosciences of California Inc.
16.12 QIAGEN N.V.
16.13 Second Genome Inc.
16.14 Thermo Fisher Scientific Inc.
16.15 Viome Inc.
16.16 CosmosID
16.17 Leucine Rich Bio Pvt. Ltd.
16.18 Microba
16.19 Microbiome Insights Inc.
16.20 Molzym GmbH & Co. KG
18.1 METHODOLOGY
18.2 RESEARCH DATA SOURCE
18.2.1 SECONDARY DATA
18.2.2 KEY DATA FROM SECONDARY
18.2.3 PRIMARY DATA
18.2.4 KEY DATA FROM PRIMARY
18.2.5 INDUSTRY INSIGHT FROM PROFESSIONAL LEADERS
18.2.6 MARKET ESTIMATION
18.2.7 MARKET ESTIMATION: TOP-DOWN AND BOTTOM-UP APPROACH
18.2.8 LEGAL DISCLAIMER
Market Segments
By TypeTraditional Sequencing Technologies
Next-Generation Sequencing
Third Generation Sequencing
By Application
Research and Academic Institutions
Pharmaceutical and Biotechnology Companies
Hospital and Clinic
Companies
Baseclear B.V.
Beijing Genomics Institute (BGI) Genomics Co. Ltd
Charles River Laboratories International Inc.
Clinical Microbiomics A/S
Eurofins Scientific SE
GENEWIZ Inc.
Illumina Inc.
Novogene Corporation
OraSure Technologies Inc.
Oxford Nanopore Technologies Inc.
Pacific Biosciences of California Inc.
QIAGEN N.V.
Second Genome Inc.
Thermo Fisher Scientific Inc.
Viome Inc.
CosmosID
Leucine Rich Bio Pvt. Ltd.
Microba
Microbiome Insights Inc.
Molzym GmbH & Co. KG
BROWSE INDUSTRY
- PROACTIVE
- QUALITY & RELIABILITY
- GLOBAL OUTREACH
- COMPETITIVE PRICING
WHY CHOOSE US
We manage our resources 24/7 to identify issues and address them before they become problems.
We are committed to providing reliable and highly accurate data with an excellent quality control system.
6 Major regions and 40+ countries level analysis accomplished.
Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery.